Debiopharm Revolutionizes Antibiotic Development with Debio 1453 Trial Against Gonorrhea
Debiopharm initiates first-in-human trial for Debio 1453, a novel antibiotic against gonorrhea, pushing innovation boundaries…
Biotechnology
Revolutionizing Cancer Treatment: CAR-T Cell Therapy Market to Reach $29 Billion by 2029
The global CAR-T cell therapy market is expected to reach $29 billion by 2029, driven…
NervGen Pharma Corp Reports Q2 Financial Results and Shareholder Update
NervGen Pharma Corp releases second-quarter financial results and provides a letter to shareholders, highlighting progress…
Medical Research and Policy Updates: A Comprehensive Review
Stay informed about the latest medical research and policy updates, including news, trends, and analysis…
Kraig Biocraft Laboratories Expands Silk Production in Southeast Asia
Kraig Biocraft Laboratories accelerates operations in two rearing centers in a premier silk-producing region of…
Hemogenyx Pharmaceuticals Secures $570,000 in Funding and Announces Director’s Dealings
Hemogenyx Pharmaceuticals raises $570,000 and announces director's dealings, marking a significant milestone in the company's…
US Court Upholds Express Preemption Defense in Medical Device Cases
A US district court has recognized that the Lohr decision does not undermine the basis…
Umbilical Cord Blood Banking Market to Reach $51.67 Billion by 2034
The global umbilical cord blood banking market is expected to grow at a CAGR of…
Revolutionizing Cancer Diagnosis: Liquid Biopsy Market Sees Unprecedented Growth
The liquid biopsy market is experiencing rapid growth, with investors pouring in over $7.3 billion…
Rakovina Therapeutics CSO Dr. Mads Daugaard to Present at Prestigious Cancer Research Retreat
Dr. Mads Daugaard, Chief Scientific Officer of Rakovina Therapeutics, has been invited to present at…